FK 506 and Mycophenolate Mofetil in Renal Transplant Recipients: Six-Month Results of a Multicenter, Randomized Dose Ranging Trial

This publication has 4 references indexed in Scilit:

• MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1
  Transplantation, 1997
• A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1
  Transplantation, 1997
• MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS
  Transplantation, 1995
• Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
  The Lancet, 1995